Shower thought, but given the limited amount of firms in the space, is there a chance that we could see the smaller players merge to form larger firms? Or is it possible that the smaller firms could be acquired by RX consulting firms "tuck ins" to strengthen their in-house IB teams (seems to be a bit of that happening right now). Or is it more likely to be a larger amount of firms in the space in the near future?
| +229 | Should My Intern Get a Return Offer? | 58 | 2d |
| +86 | UBS Accused of Favoring H-1B Workers While Cutting U.S.-Born Employees | 12 | 3h |
| +76 | Incompetent and annoying co-intern | 23 | 8h |
| +67 | Getting Laid in IB? | 28 | 2d |
| +66 | Intern keeps sleeping at work - what to tell them | 28 | 10h |
| +55 | Living in greenwich as an analyst? | 12 | 6h |
| +39 | NYC Associate Budget | 14 | 10h |
| +36 | Nauseous every morning for past 3 years in IB, anyone else? | 21 | 1d |
| +35 | Quick Thoughts on CVC AI Sale Process | 7 | 13h |
| +29 | Going out / social schedule as AN1 | 14 | 2d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
The future of RX IB consolidation is an interesting topic. Based on the most helpful WSO content, here are some insights:
Limited Number of Firms and Expertise: Restructuring (RX) is a niche field with fewer groups compared to M&A. The technical and specialized nature of RX means that there are not many bankers or firms with deep expertise in this area. This exclusivity could make consolidation appealing for smaller players looking to scale or compete with larger firms.
Potential for Mergers or Acquisitions: Smaller RX firms merging or being acquired by larger RX consulting firms is plausible. RX consulting firms like A&M and FTI already play significant roles in restructuring processes, often collaborating with RX bankers. Acquiring smaller RX IB firms could strengthen their in-house capabilities and provide a more comprehensive service offering.
Counterarguments Against Consolidation:
Future Growth of Firms: While consolidation is possible, the growth of new firms in the RX space is also likely. Economic cycles and the increasing complexity of distressed situations could create opportunities for new entrants, especially those offering innovative or specialized services.
In summary, while consolidation is a possibility, the niche and cyclical nature of RX, combined with the existing referral ecosystem, might limit the extent of such activity. At the same time, the space could see new players emerge, especially during periods of economic distress.
Sources: Pros & Cons Summary - Post-MBAs in Restructuring (RX) - any regrets?, Why You Should Consider Restructuring – Common Misconceptions/Insight on RX Groups, Wharton kids favor restructuring/distressed investing?, Top Restructuring Groups 2016, Why You Should Consider Restructuring – Common Misconceptions/Insight on RX Groups
Aut rem porro nesciunt incidunt. Libero laboriosam et voluptas quia et. Minima laborum officiis dignissimos doloribus nulla est rerum.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...